Výsledky vyhledávání - "S. De Montjoye"

POS0448 Synovial transcriptomic profiles correlate with disease activity in early untreated rheumatoid arthritis

Autor: C. Triaille, T. Sokolova, S. De Montjoye, A. Nzeusseu Toukap, L. Meric de Bellefon, A. Loriot, B. Lauwerys, P. Durez, N. Limaye

Publikováno v: Annals of the rheumatic diseases, Vol. 81, no. Suppl 1, p. 478 (2022)

BackgroundSynovitis is the common feature across all individuals with a diagnosis of rheumatoid arthritis (RA). Yet, cellular and transcriptomic alterations occuring in RA synovium are highly variable amongst patients. So far, most data on clinical-t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1853eecbb70cd7c79e79e72790911bad
https://hdl.handle.net/2078.1/261656

Zobrazit plný text záznamu

AB1161 COVID-19 in my RA clinic: data from questionnaire, vaccination, infection and flares from the RA Louvain Brussels Cohort

Autor: V. Pirson, T. Sokolova, X. Theunssens, L. Bricman, E. Sapart, S. DE Montjoye, S. Dierckx, A. Avramovska, P. Durez

Publikováno v: Annals of the rheumatic diseases, Vol. 81, no. Suppl 1, p. 1697 (2022)

BackgroundOver 5 million deaths from the COVID-19 disease have been reported in the world. Patients (pts) living with rheumatoid arthritis (RA) affecting the immune system or under immunosuppressive agent are considered as a high risk population for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8de2f87c4cc2cc87b40824b95c2f5bd0
https://hdl.handle.net/2078.1/261648

Zobrazit plný text záznamu

Acceptation de la vaccination contre la Covid-19 par les patients PR ? Résultats de la cohorte PR Louvain Bruxelles

Autor: L. Bricman, X. Theunssens, P. Durez, E. Curraj, T. Sokolova, S. Dierckx, E. Sapart, A. Avramovska, S. De Montjoye, V. Pirson

Publikováno v: Revue du Rhumatisme (Ed. Francaise : 1993)

Introduction Plus de 4 millions de décès liés au COVID-19 (SRAS-CoV-2) ont été rapportés dans le monde. Aucun traitement antiviral n’est à ce jour disponible et la vaccination reste le moyen le plus efficace pour lutter contre l’infection

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::273774a6461ed15a23b07972aea2a987
https://doi.org/10.1016/j.rhum.2021.10.553

Zobrazit plný text záznamu

Résultats de l’histopathologie des tissus synoviaux dans la PR précoce. Est-ce utile? Analyse de la cohorte belge CAP48

Autor: E. Sapart, S. De Montjoye, L. Meric de Bellefon, Bernard Lauwerys, C. Triaille, T. Sokolova, T.A. Nzeusseu, Christine Galant, A. Avramovska, S. Dierckx, Patrick Durez

Publikováno v: Revue du Rhumatisme. 87:A22-A23

Introduction La polyarthrite rhumatoide (PR) est une maladie heterogene dont la presentation clinique et les facteurs de pronostic sont differents, y compris le processus immunitaire au niveau de la synovie. Le developpement de la biopsie synoviale g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7759abdce9860739eb723511a2e41878
https://doi.org/10.1016/j.rhum.2020.10.034

Zobrazit plný text záznamu

OP0119 SHOULD WE USE BIODMARDS IN FIRST INTENTION IN EARLY RHEUMATOID ARTHRITIS?: RESULTS AT 5 YEARS FROM THE ERA LOUVAIN BRUSSELS COHORT

Autor: S. Dierckx, T. Sokolova, P. Durez, L. Meric de Bellefon, S. De Montjoye, A. Avramovska, E. Sapart, A. Nzeusseu Toukap

Publikováno v: Annals of the Rheumatic Diseases. 80:66.2-67

Background:Early effective treatment has led to major improvements in patients with rheumatoid arthritis (ERA). Low disease activity and remission are achieved earlier and in higher frequency when the initial treatment in rheumatoid arthritis include

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::283be28288d426d3f4b04444ffd11a97
https://doi.org/10.1136/annrheumdis-2021-eular.2314

Zobrazit plný text záznamu

POS1196 COVID-19 VACCINE WILLINGNESS IN RA? RESULTS FROM THE RA LOUVAIN BRUSSELS COHORT

Autor: V. Pirson, S. De Montjoye, S. Dierckx, E. Sapart, A. Avramovska, L. Bricman, T. Sokolova, T. Xavier, E. Curraj, Patrick Durez

Publikováno v: Annals of the Rheumatic Diseases. 80:880.1-880

Background:Over 2 million deaths from the COVID-19 disease have been reported in the world. Since no antiviral treatment is available, the vaccination is the most important option to fight the SARS-CoV-2 infection. Patients living with rheumatoid art

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a6e844bd248ea4ddc6188feb96b6d507
https://doi.org/10.1136/annrheumdis-2021-eular.1779

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání